Skip to main content
Traumatic Brain InjuryBrain and nervesProcedure

What this study is

The study is intended to cover two purposes: first, to develop a blood-based biomarker test for aiding the diagnosis of traumatic brain injury (TBI) in adult participants and for prognosis of outcome of TBI (CLIN12.1); and second, for monitoring the development of secondary events in adult participants diagnosed with TBI (CLIN12.2).

What's being tested

  • Blood sample collection

    Intervention · PROCEDURE

    Blood samples from each enrolled participant in CLIN12.1 and/or CLIN12.2 will be collected.

Study details

Official title
A Multicenter Prospective Study to Develop a Blood-based Biomarker Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adult Subjects (CLIN12.1) and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury (CLIN12.2)
Sponsor
Hoffmann-La Roche
Conditions
Traumatic Brain Injury
Enrolling
2,000 people
Starts
2026-02-09
Est. completion
2028-11-23
Record
View on ClinicalTrials.gov ↗